eurneffy,

ALK receives positive recommendation for EURneffy 1 mg: A needle-free anaphylaxis treatment for children

Inside Information ALK (ALKB:DC / OMX: ALK B) today announced that the Committee for Medicinal Products for Human Use (‘CHMP’)…

2 weeks ago

EURneffy approved as the first needle-free anaphylaxis treatment of adults and children in the UK

Inside Information ALK (ALKB:DC / OMX: ALK B) today announced that the Medicines and Healthcare Products Regulatory Agency (MHRA) has…

7 months ago

First market launch of the adrenaline nasal spray, EURneffy, for treatment of adults and children in Germany

ALK (ALKB:DC / OMX: ALK B) today announced the first market launch of EURneffy® 2 mg (the trade name for neffy® in…

8 months ago